Le Yin, Dan Wang, Xinyue Zhang, Xiao Wang, Hong Jiao, Xiaodan Liu, Jiaolin Zheng
{"title":"SERP1 Alleviates Cerebral Ischemia/Reperfusion Injury by Inhibiting ER Stress-Mediated Apoptosis","authors":"Le Yin, Dan Wang, Xinyue Zhang, Xiao Wang, Hong Jiao, Xiaodan Liu, Jiaolin Zheng","doi":"10.1002/cbin.70029","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Ischemic stroke is a common disease of the central nervous system, and endoplasmic reticulum (ER) stress-induced apoptosis plays a key role in brain damage following ischemic stroke. Stress-associated endoplasmic reticulum protein 1 (SERP1) is a Sec. 61-associated polypeptide induced by ER stress, which is implicated in stabilizing membrane proteins during ER stress. However, the precise molecular mechanism of SERP1 in ischemic stroke is still unknown. This study aimed to explore the protective effect of SERP1 against cerebral ischemia/reperfusion (I/R) injury. Male Sprague-Dawley rats with transient middle cerebral artery occlusion/reperfusion (tMCAO/R) were used to simulate cerebral I/R injury in vivo. To mimic the cerebral I/R injury in vitro, PC12 cells were treated with oxygen glucose deprivation/reperfusion (OGD/R). The results revealed that the SERP1 expression was increased during cerebral I/R injury in vivo and in vitro. SERP1 knockdown promoted apoptosis and ER stress as well as aggravated I/R-induced brain injury in rats with tMCAO/R, but SERP1 overexpression presented the opposite effects. SERP1 also alleviated OGD/R-induced cell damage in PC12 cells. Mechanically, SERP1 inhibited the ER stress-induced neuronal apoptosis through the PERK-EIF2α-ATF4-CHOP pathway. In conclusion, these results suggest that SERP1 may be a novel candidate gene for therapies against cerebral I/R injury.</p></div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"49 7","pages":"878-894"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology International","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cbin.70029","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Ischemic stroke is a common disease of the central nervous system, and endoplasmic reticulum (ER) stress-induced apoptosis plays a key role in brain damage following ischemic stroke. Stress-associated endoplasmic reticulum protein 1 (SERP1) is a Sec. 61-associated polypeptide induced by ER stress, which is implicated in stabilizing membrane proteins during ER stress. However, the precise molecular mechanism of SERP1 in ischemic stroke is still unknown. This study aimed to explore the protective effect of SERP1 against cerebral ischemia/reperfusion (I/R) injury. Male Sprague-Dawley rats with transient middle cerebral artery occlusion/reperfusion (tMCAO/R) were used to simulate cerebral I/R injury in vivo. To mimic the cerebral I/R injury in vitro, PC12 cells were treated with oxygen glucose deprivation/reperfusion (OGD/R). The results revealed that the SERP1 expression was increased during cerebral I/R injury in vivo and in vitro. SERP1 knockdown promoted apoptosis and ER stress as well as aggravated I/R-induced brain injury in rats with tMCAO/R, but SERP1 overexpression presented the opposite effects. SERP1 also alleviated OGD/R-induced cell damage in PC12 cells. Mechanically, SERP1 inhibited the ER stress-induced neuronal apoptosis through the PERK-EIF2α-ATF4-CHOP pathway. In conclusion, these results suggest that SERP1 may be a novel candidate gene for therapies against cerebral I/R injury.
期刊介绍:
Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect.
These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.